Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Olynka Vega"'
Autor:
Luz Alcantar-Vallin, Jose J. Zaragoza, Bladimir Díaz-Villavicencio, Karla Hernandez-Morales, Jahir R. Camacho-Guerrero, Miguel A. Perez-Venegas, Edgar J. Carmona-Morales, Alexa N. Oseguera-Gonzalez, Cesar Murguia-Soto, Gael Chávez-Alonso, José M. Arredondo-Dubois, Carlos E. Orozco-Chan, Juan A. Gómez-Fregoso, Francisco G. Rodríguez-García, Guillermo Navarro-Blackaller, Ramón Medina-González, Alejandro Martínez Gallardo-González, Gabriela J. Abundis-Mora, Olynka Vega-Vega, Guillermo García-García, Jonathan S. Chávez-Iñiguez
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundThe association between the administration of sodium–glucose cotransporter 2 inhibitors (SGLT2is) during acute kidney injury (AKI) and the incidence of major adverse kidney events (MAKEs) is not known.MethodsThis retrospective cohort stud
Externí odkaz:
https://doaj.org/article/77177721c5b247e9b43e04ecbba4a728
Autor:
Noemi Del Toro-Cisneros, Nathan Berman-Parks, Adela Uribe-Pérez, Adrián E. Caballero-Islas, Olynka Vega-Vega
Publikováno v:
Renal Failure, Vol 45, Iss 1 (2023)
AbstractBackground The renal angina index (RAI) is a tool that has been validated by several studies in the pediatric population to predict the development of severe acute kidney injury (AKI). The aims of this study were to evaluate the efficacy of t
Externí odkaz:
https://doaj.org/article/86efcad39b9f4d7a80756cdb568805da
Autor:
Olynka Vega-Vega, Noemí Del Toro-Cisneros, Víctor M. Sacoto-Romo, Juan M. Ardavín-Ituarte, Alicia Piñeirúa-Menéndez, José C. Peña-Rodríguez, Jesús M. Ramos-Gordillo, Giovanna Y. Arteaga-Müller, Héctor J. Mayorga-Madrigal, Ricardo Mendiola-Fernández, Néstor H. Cruz Mendoza, Mauricio Arvizu-Hernández, Ricardo Correa-Rotter
Publikováno v:
Revista de Investigación Clínica, Vol 75, Iss 2 (2023)
Background: Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, patients with chronic kidney disease vulnerable to suffering more severe COVID-19 disease and worse outcomes have been identified. Objective
Externí odkaz:
https://doaj.org/article/a15f3ca0ea4945f8b138b51e0d4ea516
Autor:
Juan M. Mejía-Vilet, Noemí Del Toro-Cisneros, Adrián E. Caballero-Islas, Armando J. Martínez-Rueda, John Hernández-Flores, Jefferson A. Proaño-Zamudio, Víctor M. Sacoto-Romo, Dheni A. Fernández-Camargo, Roque A. Comunidad-Bonilla, Megan A. Navarro-Gerrard, Ricardo Correa-Rotter, Olynka Vega-Vega
Publikováno v:
Revista de Investigación Clínica, Vol 75, Iss 2 (2023)
Background: A high incidence of acute kidney injury (AKI) has been reported in coronavirus disease 2019 (COVID-19) patients in critical care units and those undergoing invasive mechanical ventilation (IMV). The introduction of dexamethasone (DXM) as
Externí odkaz:
https://doaj.org/article/56bbe91d999a46fd824ffdf1cd149683
Publikováno v:
Revista de Investigación Clínica, Vol 75, Iss 6 (2023)
Membranes and sorbents play a crucial role in extracorporeal blood purification therapies, which aim to remove harmful molecules and toxins from the blood. Over the years, advancements in hemodialysis (HD) membranes and sorbents have significantly en
Externí odkaz:
https://doaj.org/article/f8fdcefc0d1a495fbf18ef17b2a6401c
Are medium cut-off membranes the future, or the promising reality for chronic hemodialysis patients?
Autor:
Noemí Del Toro-Cisneros, Erick Y. Zuñiga-González, Adrián E. Caballero-Islas, José A. Geraldo-Murillo, Mauricio Arvizu-Hernández, Olynka Vega-Vega
Publikováno v:
Revista de Investigación Clínica, Vol 75, Iss 6 (2023)
The development of hemodialysis (HD) membranes has substantially advanced in the last decade. This has resulted in the manufacturing of medium cut-off membranes (MCO) whose internal architecture is based on greater pore size and a smaller diameter, t
Externí odkaz:
https://doaj.org/article/0c5612da730f4012b6980cde4643fa1e
Publikováno v:
Revista de Investigación Clínica, Vol 75, Iss 6 (2023)
In the past decade, kidney replacement therapies have been greatly revolutionized, both for chronic patients and for those with acute kidney injury. In the field of chronic hemodialysis, the development of membranes has allowed to move from low-flux
Externí odkaz:
https://doaj.org/article/feb2eddda7c9473c92f474c92767317f
Publikováno v:
Revista de Investigación Clínica, Vol 75, Iss 6 (2023)
Acute kidney injury (AKI) is common in critically ill patients. There is no specific pharmacological treatment for established severe AKI. Therefore, the conventional therapeutic strategy is limited to the use of kidney replacement therapy (KRT) to m
Externí odkaz:
https://doaj.org/article/2616a065c97d494390ecd7485e72f8ac
Autor:
Olynka Vega-Vega, Mauricio Arvizu-Hernández, José Guillermo Domínguez-Cherit, Juan Sierra-Madero, Ricardo Correa-Rotter
Publikováno v:
Salud Pública de México, Vol 62, Iss 3, may-jun, Pp 341-347 (2020)
La pandemia del SARS-CoV-2 representa un riesgo especial para los pacientes en hemodiálisis crónica por su estado de inmunosupresión, edad avanzada y coexistencia de comorbilidades importantes, en particular patología cardiovascular, diabetes mel
Externí odkaz:
https://doaj.org/article/485bbdb199434d5988f98ceed2edaf27
Autor:
Noemí Del Toro-Cisneros, Adrián E. Caballero-Islas, Juan C. Ramírez-Sandoval, Juan M. Mejía-Vilet, Mauricio Arvizu-Hernández, Gustavo Casas-Aparicio, Jonathan Chávez-Iñiguez, Lilia M. Rizo-Topete, Olynka Vega-Vega
Publikováno v:
Revista de Investigación Clínica, Vol 74, Iss 6 (2022)
Initial reports suggested that kidney involvement after coronavirus disease 19 (COVID-19) infection was uncommon, but this premise appears to be incorrect. Acute kidney injury can occur through various mechanisms and complicate the course of up to 25
Externí odkaz:
https://doaj.org/article/faf0fdfd5ba44bb298b17b57c7afae04